Nivolumab-Induced Immune Mediated Colitis Localized to the Distal Colon: Seven Years Into Therapy

Nivolumab targets programmed cell death protein 1 (PD-1) and is used in cancer treatment by increasing the immune response. It has rarely been associated with immune-mediated colitis (IMC). We present a 66-year-old man with metastatic lung adenocarcinoma, treated with nivolumab for seven years, who...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Curēus (Palo Alto, CA) CA), 2024-10, Vol.16 (10), p.e72373
Hauptverfasser:	Nassif, Christian J, Nassif, Imad I, Todorov, Mouna
Format:	Artikel
Sprache:	eng
Schlagworte:	Atrophy Biopsy Cancer Colon Colonoscopy Edema Endoscopy Erythema Gastroenterology Immunotherapy Inflammatory bowel disease Internal Medicine Lymphatic system Metastasis Monoclonal antibodies Oncology Steroids Targeted cancer therapy Tomography
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!